Viewing Study NCT00103558


Ignite Creation Date: 2025-12-25 @ 12:03 AM
Ignite Modification Date: 2025-12-25 @ 10:02 PM
Study NCT ID: NCT00103558
Status: COMPLETED
Last Update Posted: 2015-10-02
First Post: 2005-02-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Lumiliximab in Combination With FCR in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)
Sponsor: Biogen
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module